PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES
Abstract
Authors
M Lamotte L Annemans T Evers M Kubin
M Lamotte L Annemans T Evers M Kubin
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now